20089 TA+Lucentis Combo Intravitreal Injections for Treatment of Neovascular Age-related Macular Degeneration (AMD)

NCT01175395 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Age-Related Macular Degeneration
Choroidal Neovascularization

Interventions

DRUG: IBI-20089/Lucentis

Sponsor

University of Illinois at Chicago

Collaborators

[object Object]